The second in its series of steroid hormone kits based on tandem mass spectrometry, the AbsoluteIDQ Stero17 kit can analyse up to 80 samples per batch, requires a sample volume of only 500 μL, and enables the most comprehensive simultaneous quantification of a steroid panel using HPLC-MS/ MS as well as improved high-throughput UHPLC–MS/MS analysis. The kit covers the standardized quantitative analysis of 17 of the most important steroid hormones from only a single blood sample using UHPLC-MS/MS, a technology meeting the most stringent quality control criteria for routine diagnostics, ensuring a high level of analytical sensitivity and selectivity, and guaranteeing superior accuracy and excellent precision for robust results. The kit, which has been approved by proficiency tests, comes complete with isotopelabelled internal standards, reagents and protocols for sample pre¬paration based on solid-phase extraction in a 96-well plate format and subsequent UHPLC-ESI-MS/ MS analysis in highly specific multiple reaction monitoring (MRM) mode and a tightly quality-controlled workflow. Given the significant role of steroid hormones in the body, their quantitative analysis in clinical diagnostics and research-based applications can be crucial. Compared to immunoassay-based tests, LC-MS/MS analysis offers the advantages of multiplexing (simultaneous analysis of multiple target analytes), higher specificity (by so-called multiple reaction monitoring (MRM), greater dynamic range of the calibration and lower inter-laboratory variability (including diversity in sample preparation, calibrators and analytical methods).
Read more

The KL-800 Semi-Auto Chemistry Analyser offers four channels designed to carry out four simultaneous tests, eight filters (340nm~700nm) and allows up to 200 tests to be programmed. It is energy efficient with a sleep mode to prolong the lifespan of the light source and equipped with power failure protection. The analyser is available with a standard RS232 interface and optional touch-screen, keyboard and mouse. It offers real time monitoring of reaction curve and process, an auto wash feature and an accurate temperature control system.
Read more

Processing pathogen panels in seconds, the autoSCAN-4 system simplifies identification and antibiotic suceptibility testing while standardising results. It can be used as an excellent supplemental system for difficult organisms or as a primary instrument for low volume usage. The system includes LabPro Information Management software designed to simplify workflow and minimise technologist interaction while accommodating differing regional and institutional environments through extensive customisation features. The optional LabPro AlertEX software eliminates manual review for unusual conditions or results and integrates institution-specific resolution guidance into the workflow. Panels include conventional panels with direct, non-ID-dependant Minimal Inhibitory Concentrations (MICs), to help zero in on emerging resistance, and speciality ID panels for reduced TAT when speed is critical.
Read more

It has been estimated that 3 to 4 million people are infected with hepatitis C virus (HCV) each year. Four out of five people develop chronic hepatitis C infection, which can subsequently lead to liver cirrhosis and/or liver cancer. Early detection is the key to combating hepatitis; hepatitis C infection can be effectively controlled or treated if it is diagnosed early. HCV ELISA and rapid tests are widely used for screening and diagnosis of hepatitis C infection. These tests use specific antigens from the structural region and non-structural regions of the virus to detect the presence of antibodies to HCV. Reactive samples from screening tests are then confirmed by immunoblot assay. The MULTISURE HCV Antibody Assay is a qualitative immunochromatographic assay, intended for the detection of antibodies specific to HCV core, NS3, NS4 and NS5 antigens. The test is based on the capture of HCV antibodies using immobilised HCV recombinant antigens on a nitrocellulose membrane and the subsequent detection of captured analyte using goat anti-human IgG conjugated to colloidal gold. It has been developed from the patented reverse-flow test platform, giving greater sensitivity and easy-to-read visual signals. Similar to a confirmatory immunoblot, this assay can detect and differentiate the structural and non-structural HCV proteins. The test result pattern may, therefore, offer information such as the possible phase of the Hepatitis C infection. This simple and rapid assay takes only 15 minutes and is easy to use. It is an instrument-free platform and does not require highly trained personnel to perform the test, thus making it suitable for use in a point-of-care setting. With shortened turnaround time, patients are diagnosed early and have wider access to treatment and care.

Read more